Questions for Posters #1-19:

Size: px
Start display at page:

Download "Questions for Posters #1-19:"

Transcription

1 POSTER #1: Questions for Posters #1-19: 1. Bacterial load in urine samples was performed by assessing: a. Copy numbers of 16s RNA sequences of bacteria b. Copy numbers of whole genome sequencing of bacteria c. Assessment is not necessary since urine is always sterile 2. In this study, antibiotic prophylaxis: a. Wiped out all harmful bacteria while leaving only normal flora behind b. Increased overall bacterial loads in urine samples c. Had no effect 3. Sequencing results were obtained using: a. RTqPCR b. Sanger sequencing c. Next generation sequencing POSTER #2: 1. Testing methods included: a. Gradient diffusion, disc diffusion, PBP2a detection, and modified carbapenem inactivation b. Gradient diffusion, disc diffusion, microdilution, modified carbapenem inactivation, and Sanger sequencing c. Gradient diffusion, disc diffusion, microdilution, modified carbapenem inactivation, and DNA microarray 2. Fosfomycin was shown to have greater activity against CP-CRE compared to non-cp-cre 3. CP-CRE stands for: a. Carbapenemase-producing carbapenem-resistant Enterobacteriaceae b. Carbapenemase-producing carbapenem-resistant Enterococcus c. Carbapenem-producing carbapenemase-resistant Enterobacteriaceae POSTER #3: 1. Colistin resistance mechanism includes a. production of the PBP2a binding protein b. modification to lipid A by chromosomal and plasmid-mediated approaches (mcr genes) C. macrolide efflux 2. Isolates with an MIC 4 µg/ml to colistin are considered to be negative for the mcr genes.

2 3. Colistin MICs were read after POSTER #4: a. 4-hour incubation b. 6 hour incubation c hour incubation 1. Which of the following is NOT a proposed factor in checkpoint blockade immunotherapy efficacy? a. Cancer mutational burden b. Patient microbiome c. Stage and grade of cancer d. Location of tumors 2. This pilot experiment was designed to test all of the following parameters EXCEPT: a. Optimal time for gut colonization b. Differences in immune response to tumor c. Response to checkpoint blockade therapy d. Differences in tumor growth 3. The cancer cell line used in this pilot is an aggressive, metastatic tumor cell line. a. Colorectal cancer b. Lymphoma c. Lung cancer d. Melanoma POSTER #5: 1. The 8 action steps for this study were a. Think, define, meet, discuss, consent, cooperate, collaborate, and feedback b. Think, decide, meet, define, consent, cooperate, collect information, and feedback c. Think, define, measure, discuss, consent, cooperate, collaborate, and seek information 2. One purpose of a rapid autopsy is to evaluate the efficacy of cancer treatments 3. The limiting factor for rapid autopsies is a. Number of tissue sources that can be collected b. Coordination of efforts across disciplines to achieve rapid results c. Time

3 POSTER #6: 1. Testing by the GenePOC CDiff test required how much unformed stool? a. 5 ml b. 5 μl c. 5 L 2. The GenePOC assay was compared to a. Real-time polymerase chain reaction to detect tcdb of toxigenic C. difficile b. Recovery by standard stool culture c. Toxigenic culture and the BD MAX Cdiff assay 3. Compared to the BD MAX Cdiff assay, the GenePOC assay had a specificity of a. 100% b. 95.5% c. 69.6% POSTER #7: 1. The majority of journal articles studied were from the following discipline: a. Urology b. Oncology c. Pathology 2. The most frequently used classification for grouping GS is the D Amico 3. Which statement is most accurate according to the authors of this poster? a. Articles lacking a pathologist author used closer to ideal groupings b. Articles with student authors used closer to ideal groupings c. Articles with a pathologist author used closer to ideal groupings POSTER #8: 1. Which statement is true? a. All genotyping assays are able to detect HCV recombinant variants b. Only genotyping assays targeting 5 UTR, Core/E1, or NS5 sequences are able to detect HCV recombinant variants c. Genotyping assays targeting 5 UTR, Core/E1, or NS5 sequences are not able to detect HCV recombinant variants 2. In the recombinant HCV genome crossover was found: a. At the NS2/NS3 junction at or near nucleotide 11,445 b. At thens2/ns3 junction at or near nucleotide 3,345 c. At thegt2 to Gt1 junction at or near nucleotide 3,345

4 3. Individuals with a recombinant version of HCV may be easily inaccurately genotyped leading to increased virologic relapse and decreased treatment efficacy when treated with Gt2-specific, Gt1-specific, or pan-genotypic regimens POSTER #9: 1. The purpose of the saponin step is to a. Deplete host DNA in order to better recover microbial DNA b. Deplete microbial DNA in order to better recover host DNA c. decrease the number of reads due to possible contamination 2. Analysis of Next Generation Sequencing data is very simple 3. Kraken and Pavian are a. programs that can be used to help analyze next generation sequencing data b. programs necessary to run the assay c. programs that will do all the next generation sequencing data analysis for you without any user intervention or input Poster #10: 1. How many infectious units would have been missed due to false negative test results? a. 231 b. 321 c In this poster, what does RDT stand for? a. Rapid Diagnostic Test b. Regional Detailed Test c. Radioactive Diagnostic Test 3. Based on the Map of the Whole Blood Collections/100,000 Population on this poster, how many collections do the USA and Australia have? a b c. 30 Poster #11: 1. How long does AABB state that cryoprecipitate is good for? a. 1-2 hours b. 4-6 hours c. 24 hours d. 5 days

5 2. At 120 hours, how many pooled cryoprecipiate tested met the AABB required fibrinogen levels? a. 0 b. 5 c. 10 d What organism was identified from the culture of one of the 80 bags of pooled cryoprecipitate? a. Staphylococcus aureus b. Escherichia coli c. Staphylococcus epidermidis d. Yersinia pestis Poster #12: 1. What Streptococcus are included in the non-group A Streptococcus group in this poster? a. GBS (Gr. B Streptococcus) b. GCS (Gr. C Streptococcus) c. GGS (Gr. G Streptococcus) d. All of the above 2. Based on Figure 1, what relative risk ratio of clinical characteristics seem to occur more with GBS than GAS? a. Diabetes b. Oral abscesses c. Throat erythema 3. Which of the following non-group A Streptococcus present with symptoms indicative of viral respiratory tract infections? a. GCS b. GBS c. GGS Poster #13: 1. Based on this poster, what multi-drug resistant organisms should Colistin only be used for? a. Acinetobacter b. MRSA c. Pseudomonas d. A and C 2. At what concentration of EDTA did this poster find was sufficient to reduce the MIC of colistin? a. 1 mm b. 2mM c. 3 mm 3. In Table 3 of the poster, which column consistently shows the lowest MIC values in MCR-1 isolates? a. Macrobroth Dilution

6 Poster #14: b. Microbroth Dilution COL c. Microbroth Dilution POLB d. CPDE Elution e. CBDE with EDTA 1. Which ankryin-like (ank) is critical for late expression of MVA in non-permissive mammalian cells? a. 65KD b. 68 KD c. 63 KD 2. What type of cells were infected with MVA or 186 virus? a. RHMK b. AGMK c. HeLa 3. According to the poster, what homologous gene deletion did not cause similar defects of the VACV as 186R? a. B18R b. B17R c. B19R Poster #15: 1. How many pathogens does the FilmArray system detect? a. 20 b. 22 c What is one disadvantage of this assay in Uganda? a. It is unable to detect non-kpc carbapenemases. b. It is a multiplex assay. c. It is able to identify polymicrobial growth. 3. Which of the following where admission diagnosis from the patients in the study? a. Breast cancer b. Prostate cancer c. Stomach cancer d. All of the above Poster #16: 1. What Staphylococcus species is not included in the Staphylococcus intermedius group (SIG)? a. Staphylococcus aureus b. Staphylococcus pseudintermedius c. Staphylococcus delphini 2. What automated systems were compared in this poster?

7 a. MicroScan WalkAway b. BD Phoenix c. Vitek 2 d. All of the above 3. Which of the following is NOT a key finding from this poster? a. No isolate was misidentified as S. aureus. b. All of the systems were able to identify S. delphini to the species level. c. Staphylococcus haemolyticus was identified as a species other than SIG. Poster #17: 1. What has initiated the over the counter DNA-related health and beauty products? a. The Human Genome Project. b. Ads on television. c. The FDA 2. What are case studies that were included in this poster? a. Customized dietary supplements based on gene sequencing. b. Skin creams utilizing DNA repair enzyme technology. c. DNA-supporting dietary formulations. d. All of the above. e. None of the above. 3. Which of the following is NOT a finding of this poster? a. Consumers enjoy the idea of controlling their health and beauty regimens. b. DNA sequencing and DNA targeting appeals to the idea of personalizing healthcare. c. All of these products did what they said they would. Poster # 18: 1. What factors does thrombin activate which promote clot formation? a. FXIII b. FV c. FVIII d. All of the above 2. What conclusion was NOT drawn from this poster? a. Micro particles and PF 1+2 were independent of each other. b. There was an observed correlation between thrombin generation and PF 1+2. c. In patients with HIV-1, markers of thrombin generation are elevated. 3. What cells release microparticles? a. Monocytes and platelets. b. Red blood cells. c. Eosinophils. Poster # 19: 1. What blood cells were NOT analyzed in this poster?

8 a. T- and B-cells b. C-cells c. NK cells 2. What race had the highest % of participants in this study? a. Caucasian b. African American c. Other 3. Which of the following were a finding from this study? a. The rates of T (CD4+ and CD8+) and B and NK cells were relatively stable throughout adult life. b. Individuals have large variations between their number of lymphocytes. c. CMV infection did not appear to influence rates of change in the lymphocyte numbers. d. All of the above.

Noelisa Montero, MPH. Epidemiologist Consultant. October 19, 2017 Connecticut Department of Public Health Healthcare Associated Infections Program

Noelisa Montero, MPH. Epidemiologist Consultant. October 19, 2017 Connecticut Department of Public Health Healthcare Associated Infections Program Carbapenem-resistant Enterobacteriaceae (CRE) in Connecticut: Collaborative Development of a Characterization Panel and Testing of Carbapenemase Genetic Markers, 2017 Noelisa Montero, MPH Epidemiologist

More information

10/4/16. mcr-1. Emerging Resistance Updates. Objectives. National Center for Emerging and Zoonotic Infectious Diseases. Alex Kallen, MD, MPH, FACP

10/4/16. mcr-1. Emerging Resistance Updates. Objectives. National Center for Emerging and Zoonotic Infectious Diseases. Alex Kallen, MD, MPH, FACP National Center for Emerging and Zoonotic Infectious Diseases Emerging Resistance Updates Alex Kallen, MD, MPH, FACP Lead Antimicrobial Resistance and Emerging Pathogens Team Prevention and Response Branch

More information

The Antibiotic Resistance Laboratory Network

The Antibiotic Resistance Laboratory Network The Antibiotic Resistance Laboratory Network 1 Antibiotic Resistance in the United States Sickens >2 million people per year Kills at least 23,000 people each year Plus 15,000 each year from C. difficile

More information

Public Health Surveillance for Multi Drug Resistant Organisms in Orange County

Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Public Health Surveillance for Multi Drug Resistant Organisms in Orange County Matt Zahn, MD Medical Director Epidemiology and Assessment Orange County Public Health Antimicrobial Mechanisms of Action

More information

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host

Chain of Infection Agent Mode of transmission Contact (direct, indirect, droplet spread) Airborne Common-vehicle spread Host Goals Microbiology of Healthcare-associated Infections William A. Rutala, Ph.D., M.P.H. Director, Statewide Program for Infection Control and Epidemiology and Research Professor of Medicine, University

More information

MICROBIOLOGICAL PROFILE

MICROBIOLOGICAL PROFILE Evans Vanodine International plc G L O B A L H Y G I E N E S O L U T I O N S HANDSAN MICROBIOLOGICAL PROFILE 2 INTRODUCTION HANDSAN is a ready to use, quick acting and highly effective, alcohol based hygienic

More information

NONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN

NONFERMENTING GRAM NEGATIVE RODS. April Abbott Deaconess Health System Evansville, IN NONFERMENTING GRAM NEGATIVE RODS April Abbott Deaconess Health System Evansville, IN OBJECTIVES Discuss basic limitations to assessing carbapenem resistance in nonfermenting GNRs Discuss antimicrobial

More information

ALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella

ALERT. Clinical microbiology considerations related to the emergence of. New Delhi metallo beta lactamases (NDM 1) and Klebsiella ALERT Clinical microbiology considerations related to the emergence of New Delhi metallo beta lactamases (NDM 1) and Klebsiella pneumoniae carbapenemases (KPC) amongst hospitalized patients in South Africa

More information

The Year in Infection Control

The Year in Infection Control The Year in Infection Control Andie Lee Departments of Infectious Diseases and Microbiology Royal Prince Alfred Hospital Sydney, Australia 1 1.223 million Pubmed publications last 12 months 2 Selection

More information

National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats

National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats National Center for Emerging and Zoonotic Infectious Diseases The Biggest Antibiotic Resistance Threats Jean B. Patel, PhD, D(ABMM) Science Lead, Antibiotic Resistance and Coordination Unit Centers for

More information

Adenium Biotech. Management: - Peter Nordkild, MD, CEO, ex Novo Nordisk, Ferring, Egalet - Søren Neve, PhD, project director, ex Lundbeck, Novozymes

Adenium Biotech. Management: - Peter Nordkild, MD, CEO, ex Novo Nordisk, Ferring, Egalet - Søren Neve, PhD, project director, ex Lundbeck, Novozymes Adenium Biotech Management: - Peter Nordkild, MD, CEO, ex Novo Nordisk, Ferring, Egalet - Søren Neve, PhD, project director, ex Lundbeck, Novozymes Board of Directors: - Stephan Christgau, PhD, chairman,

More information

PATHOGEN DETECTION WITH THE FILMARRAY

PATHOGEN DETECTION WITH THE FILMARRAY PATHOGEN DETECTION WITH THE FILMARRAY The System Sample-to-Answer in an Hour Single sample Multiple samples The FilmArray integrates sample preparation, amplification, detection, and analysis all into

More information

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel plus

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel plus Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel plus Laboratory Protocols for Use with a ZeptoMetrix NATtrol Verification Panel Purpose The Clinical Laboratory

More information

Module Four: The GI System Module Five: The Gut Microbiome. The GI System. LLiana Shanti, CN

Module Four: The GI System Module Five: The Gut Microbiome. The GI System. LLiana Shanti, CN Module Four: The GI System Module Five: The Gut Microbiome The GI System LLiana Shanti, CN www.healthmasteryinstitute.com Review Review Review The Gut Hippocrates has been quoted as saying death sits in

More information

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011

Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Guidance on screening and confirmation of carbapenem resistant Enterobacteriacae (CRE) December 12, 2011 Objectives: To discuss the guidelines for detection of CRE in the laboratory setting. To review

More information

INFECTIOUS DISEASE. Page 2

INFECTIOUS DISEASE. Page 2 Infectious disease Advantages OF TESTING INFECTIOUS DISEASE We are in the middle of a paradigm shift in infectious disease diagnostic testing. As we move from targeted infectious disease testing to a syndromic

More information

Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory

Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory Spread of carbapenems resistant Enterobacteriaceae in South Africa; report from National Antimicrobial Resistance Reference Laboratory Olga Perovic*, Ashika Singh-Moodley, Samantha Iyaloo 5 th November

More information

Treatment of febrile neutropenia in patients with neoplasia

Treatment of febrile neutropenia in patients with neoplasia Treatment of febrile neutropenia in patients with neoplasia George Samonis MD, PhD Medical Oncologist Infectious Diseases Specialist Professor of Medicine The University of Crete, Heraklion,, Crete, Greece

More information

Infection Prevention & Control Core Skills Level 2

Infection Prevention & Control Core Skills Level 2 Infection Prevention & Control Core Skills Level 2 Learning outcomes Risk assessment of patients Critical examination of the situation MRSA, CDT & CPE Ongoing challenges future-proofing infection control

More information

CONSIDERATIONS IN UTI DETECTION AND POTENTIAL IMPACT ON ANTIBIOTIC STEWARDSHIP

CONSIDERATIONS IN UTI DETECTION AND POTENTIAL IMPACT ON ANTIBIOTIC STEWARDSHIP CONSIDERATIONS IN UTI DETECTION AND POTENTIAL IMPACT ON ANTIBIOTIC STEWARDSHIP ERIN H. GRAF, PHD, D(ABMM) Director, Infectious Disease Diagnostics Laboratory Assistant Professor, Clinical Pathology and

More information

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel

Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel Protocols for Laboratory Verification of Performance of the BioFire FilmArray Pneumonia Panel Laboratory Protocols for Use with a ZeptoMetrix NATtrol Verification Panel Purpose The Clinical Laboratory

More information

PATHOGENICITY OF MICROORGANISMS

PATHOGENICITY OF MICROORGANISMS PATHOGENICITY OF MICROORGANISMS Some microorganisms are : 1- Harmless microorganism, as normal flora 2- Harmfull microorganism, as pathogenic. A pathogenic microorganism is defined as one that causes or

More information

The Potential For Microbiome Modification In Critical Illness. Deborah Cook

The Potential For Microbiome Modification In Critical Illness. Deborah Cook The Potential For Microbiome Modification In Critical Illness Deborah Cook To review Objectives The microbiome & concepts about its modification during critical illness Interventions Predisposition to

More information

Update of the CDC/HICPAC Guideline: Infection Prevention in Healthcare Personnel

Update of the CDC/HICPAC Guideline: Infection Prevention in Healthcare Personnel Update of the CDC/HICPAC Guideline: Infection Prevention in Healthcare Personnel David T. Kuhar, M.D. Medical Epidemiologist HICPAC Meeting June 6, 2013 National Center for Emerging and Zoonotic Infectious

More information

Dear Healthcare Provider, The information contained here may be very important to your practice. Please take a moment to review this document.

Dear Healthcare Provider, The information contained here may be very important to your practice. Please take a moment to review this document. February 2018 Dear Healthcare Provider, The information contained here may be very important to your practice. Please take a moment to review this document. TEST BULLETIN CHLAMYDIA/GONORRHEA SPECIMEN COLLECTION

More information

Reducing Time to Result for Urinary Tract Pathogen Detection Utilizing Real-Time PCR Technology

Reducing Time to Result for Urinary Tract Pathogen Detection Utilizing Real-Time PCR Technology Reducing Time to Result for Urinary Tract Pathogen Detection Utilizing Real-Time PCR Technology David A. Baunoch, Ph.D Chief Scientific Officer Pathnostics Evolving Picture of Urinary Tract Infections

More information

What s new in Infectious Diseases. Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital

What s new in Infectious Diseases. Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital What s new in Infectious Diseases Petronella Adomako, MD Infectious Disease Specialist Mckay-Dee Hospital None Disclosures Objectives New information in infectious diseases. New diseases and outbreaks.

More information

Resistance to Polymyxins in France

Resistance to Polymyxins in France Resistance to Polymyxins in France Paris Prof. Patrice Nordmann NDM producers in Enterobacteriaceae The polymyxins; colistin and polymyxin B Colistin - Synthesis by Bacillus polymyxa spp colistinus -

More information

Pathogenicity of Infectious Diseases

Pathogenicity of Infectious Diseases Pathogenicity of Infectious Diseases Pathogenicity of Infectious Diseases HOST DISEASE TRIAD PATHOGEN ENVIRONMENT OTHER MICROBES Microbial Interactions KOCH'S POSTULATES Four criteria that were established

More information

Introduction to the Impact of Resistance in Hepatitis C

Introduction to the Impact of Resistance in Hepatitis C Introduction to the Impact of Resistance in Hepatitis C Sponsored by AbbVie 2/1/2017 Presented by Sammy Saab, MD, MPH, FACG, AGAF, FAASLD February 1 st, 2017 1 AbbVie disclosures This is an Abbvie sponsored

More information

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders?

Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? Pneumonia Aetiology Why is it so difficult to distinguish pathogens from innocent bystanders? David Murdoch Department of Pathology University of Otago, Christchurch Outline Background Diagnostic challenges

More information

HOSPITAL EPIDEMOLOGY AND INFECTION CONTROL: STANDARD AND TRANSMISSION-BASED ISOLATION

HOSPITAL EPIDEMOLOGY AND INFECTION CONTROL: STANDARD AND TRANSMISSION-BASED ISOLATION Appendix 1: Carbapenem-Resistant Enterobacteriacaea (CRE) I. Definition: 2015 CDC definition of CRE are Enterobacteriaceae 1 that are: A. Resistant to any carbapenem antimicrobial (i.e., minimum inhibitory

More information

New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility

New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility New Molecular Diagnostic Assays for Solana Performance Assessment, Workflow Analysis, and Clinical Utility Gerald A. Capraro, Ph.D., D(ABMM) Director, Clinical Microbiology Carolinas Pathology Group Atrium

More information

Immune System. Name: Class: Date: Multiple Choice Identify the choice that best completes the statement or answers the question.

Immune System. Name: Class: Date: Multiple Choice Identify the choice that best completes the statement or answers the question. Class: Date: Immune System Multiple Choice Identify the choice that best completes the statement or answers the question. 1. Which of the bacteria is the cause of pneumonia? a. staphylococci c. Treponema

More information

Lecture 2: Virology. I. Background

Lecture 2: Virology. I. Background Lecture 2: Virology I. Background A. Properties 1. Simple biological systems a. Aggregates of nucleic acids and protein 2. Non-living a. Cannot reproduce or carry out metabolic activities outside of a

More information

2018 CNISP HAI Surveillance Case definitions

2018 CNISP HAI Surveillance Case definitions 2018 CNISP HAI Surveillance Case definitions The following case definitions for the surveillance of healthcare-associated infections (HAIs) are used by all acute-care hospitals that participate in the

More information

Medical Officer of Health Medical Director, Travel Health and Tropical Medicine Services Winnipeg Regional Health Authority

Medical Officer of Health Medical Director, Travel Health and Tropical Medicine Services Winnipeg Regional Health Authority DNA Vaccines The Future of Travel Health Vaccines? Or Just a Bad Idea? Dr. Pierre J. Plourde Medical Officer of Health Medical Director, Travel Health and Tropical Medicine Services Winnipeg Regional Health

More information

Influenza-Associated Pediatric Deaths Case Report Form

Influenza-Associated Pediatric Deaths Case Report Form STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Form approved OMB No. 0920-0007 Last Name: First Name: County: Address: City: State, Zip: Patient Demographics 1. State: 2. County: 3. State

More information

3base The Science Behind EasyScreen Molecular Diagnostic Assays. Nucleic Acid Conversion Technology

3base The Science Behind EasyScreen Molecular Diagnostic Assays. Nucleic Acid Conversion Technology 3base The Science Behind EasyScreen Molecular Diagnostic Assays Nucleic Acid Conversion Technology 1 Topics 3base Technology Overview Technical Advantages of 3base Validation of 3base Specificity Validation

More information

The CLSI Approach to Setting Breakpoints

The CLSI Approach to Setting Breakpoints The CLSI Approach to Setting Breakpoints Jean B. Patel, PhD, D(ABMM) Deputy Director, Office of Antimicrobial Resistance Division of Healthcare Quality Promotion National Center for Emerging and Zoonotic

More information

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays

Innovations in nucleic acid amplification technologies. Automated platforms for NAT. Microfluidics Digital PCR Innovations in nucleic acid microarrays About the author Disclaimer EXECUTIVE SUMMARY Molecular diagnostic technologies Healthcare-associated infections Sexually transmitted HPVs HIV and hepatitis viruses Market outlook and forecasts Molecular

More information

Overview of Immunology. Evolution CORE CONCEPTS IN IMMUNOLOGY. Cliona O Farrelly

Overview of Immunology. Evolution CORE CONCEPTS IN IMMUNOLOGY. Cliona O Farrelly Overview of Immunology Cliona O Farrelly Professor Comparative Immunology, School of Biochemistry & Immunology & School of Health Sciences cliona.ofarrelly@tcd.ie CORE CONCEPTS IN IMMUNOLOGY 1. Identification

More information

Customary urine test is the dip stick and the mid-stream culture of voided urine. Up to 77% of cystitis cases are cultured

Customary urine test is the dip stick and the mid-stream culture of voided urine. Up to 77% of cystitis cases are cultured 9 million visits/year! Customary urine test is the dip stick and the mid-stream culture of voided urine. Up to 77% of cystitis cases are cultured Interpretation of the culture result has been controversial-

More information

Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No

Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No Influenza-Associated Pediatric Mortality Case Report Form Form Approved OMB No. 0920-0004 STATE USE ONLY DO NOT SEND INFORMATION IN THIS SECTION TO CDC Last Name: First Name: County: Address: City: State,

More information

Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL

Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL Methods for colistin testing What works and what does not? Erika Matuschek, Ph D EUCAST Development Laboratory, EDL 3 rd joint meeting on AMR in Salmonella and Campylobacter, Copenhagen 7 April 2017 Antimicrobial

More information

Luciferase (Firefly and Renilla) Expression Stable Cell Lines

Luciferase (Firefly and Renilla) Expression Stable Cell Lines Luciferase (Firefly and Renilla) Expression Stable Cell Lines Catalog # Product Amount HEK293 Host cell line SC002-Bsd SC002-Puro SC002-Neo SC002-GB SC002-GP SC002-RB SC002-RP SC020-Puro SC020-RP SC021-Puro

More information

Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract).

Acute respiratory illness This is a disease that typically affects the airways in the nose and throat (the upper respiratory tract). Influenza glossary Adapted from the Centers for Disease Control and Prevention, US https://www.cdc.gov/flu/glossary/index.htm and the World Health Organization http://www.wpro.who.int/emerging_diseases/glossary_rev_sept28.pdf?ua=1

More information

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV

LESSON 4.6 WORKBOOK. Designing an antiviral drug The challenge of HIV LESSON 4.6 WORKBOOK Designing an antiviral drug The challenge of HIV In the last two lessons we discussed the how the viral life cycle causes host cell damage. But is there anything we can do to prevent

More information

Antimicrobial Resistance Surveillance Data Requirements for Priority Organisms

Antimicrobial Resistance Surveillance Data Requirements for Priority Organisms Antimicrobial Resistance Surveillance Data Requirements for Priority Organisms The Communicable and Infectious Disease Steering Committee Antimicrobial Resistance Surveillance Task Group Final Report to

More information

IP Lab Webinar 8/23/2012

IP Lab Webinar 8/23/2012 2 What Infection Preventionists need to know about the Laboratory Anne Maher, MS, M(ASCP), CIC Richard VanEnk PhD, CIC 1 Objectives Describe what the laboratory can do for you; common laboratory tests

More information

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association

Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Antimicrobial prophylaxis in liver transplant A multicenter survey endorsed by the European Liver and Intestine Transplant Association Els Vandecasteele, Jan De Waele, Dominique Vandijck, Stijn Blot, Dirk

More information

cure research HIV & AIDS

cure research HIV & AIDS Glossary of terms HIV & AIDS cure research Antiretroviral Therapy (ART) ART involves the use of several (usually a cocktail of three or more) antiretroviral drugs to halt HIV replication. ART drugs may

More information

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication

LESSON 4.4 WORKBOOK. How viruses make us sick: Viral Replication DEFINITIONS OF TERMS Eukaryotic: Non-bacterial cell type (bacteria are prokaryotes).. LESSON 4.4 WORKBOOK How viruses make us sick: Viral Replication This lesson extends the principles we learned in Unit

More information

MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions

MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions MHSAL Guidelines for the Prevention and Control of Antimicrobial Resistant Organisms (AROs) - Response to Questions Dr. Andrew Walkty Medical Microbiologist, Diagnostic Services Manitoba (DSM) June. 17,

More information

CURRENT INFECTIOUS DISEASE ISSUES. 11/2/15 Regina Won, MD

CURRENT INFECTIOUS DISEASE ISSUES. 11/2/15 Regina Won, MD CURRENT INFECTIOUS DISEASE ISSUES 11/2/15 Regina Won, MD Disclosures None Objectives Discuss common organisms seen on the wards Discuss infection control issues associated with these common organisms Discuss

More information

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator

Laboratory CLSI M100-S18 update. Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Nebraska Public Health Laboratory 2008 CLSI M100-S18 update Paul D. Fey, Ph.D. Associate Professor/Associate Director Josh Rowland, M.T. (ASCP) State Training Coordinator Agenda Discuss 2008 M100- S18

More information

Resistance to linezolid in enterococci and staphylococci referred to the national reference laboratory

Resistance to linezolid in enterococci and staphylococci referred to the national reference laboratory Resistance to linezolid in enterococci and staphylococci referred to the national reference laboratory Dr Danièle Meunier, AMRHAI BSAC - Antimicrobial Susceptibility Testing User Days Oxazolidinone Linezolid

More information

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae

GUIDE TO INFECTION CONTROL IN THE HOSPITAL. Carbapenem-resistant Enterobacteriaceae GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 47: Carbapenem-resistant Enterobacteriaceae Authors E-B Kruse, MD H. Wisplinghoff, MD Chapter Editor Michelle Doll, MD, MPH) Topic Outline Key Issue Known

More information

Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH

Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong. Title. Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH Title Emergence of Klebsiella pneumoniae ST258 with KPC-2 in Hong Kong Author(s) Ho, PL; Tse, CWS; Lai, EL; Lo, WU; Chow, KH Citation International Journal Of Antimicrobial Agents, 2011, v. 37 n. 4, p.

More information

4/17/2019 DISCLOSURES OBJECTIVES GI MICROBIOME & HEALTH: A REVIEW. Nancy C. Kois, MD, FCAP Contemporary Pathology Services. There are no disclosures

4/17/2019 DISCLOSURES OBJECTIVES GI MICROBIOME & HEALTH: A REVIEW. Nancy C. Kois, MD, FCAP Contemporary Pathology Services. There are no disclosures GI MICROBIOME & HEALTH: A REVIEW Nancy C. Kois, MD, FCAP Contemporary Pathology Services DISCLOSURES There are no disclosures OBJECTIVES Definitions: GI microbiota, GI microbiome, probiotic, prebiotic

More information

Below is an overview of the oral and poster presentations featuring cefiderocol and S at IDWeek 2017:

Below is an overview of the oral and poster presentations featuring cefiderocol and S at IDWeek 2017: SHIONOGI TO HIGHLIGHT RESEARCH ON CEFIDEROCOL (S-649266), A SIDEROPHORE CEPHALOSPORIN, AND S-033188, A CAP-DEPENDENT ENDONUCLEASE INHIBITOR FOR TREATMENT OF INFLUENZA, AT IDWEEK 2017 OSAKA, Japan and FLORHAM

More information

Technical Bulletin No. 162

Technical Bulletin No. 162 CPAL Central Pennsylvania Alliance Laboratory Technical Bulletin No. 162 cobas 6800 HCV Viral Load Assay - New Platform - June 1, 2017 Contact: Heather Habig, MLS (ASCP) CM, MB CM, 717-851-1422 Operations

More information

NEONATAL SEPSIS. Dalima Ari Wahono Astrawinata Departemen Patologi Klinik, FKUI-RSCM

NEONATAL SEPSIS. Dalima Ari Wahono Astrawinata Departemen Patologi Klinik, FKUI-RSCM NEONATAL SEPSIS Dalima Ari Wahono Astrawinata Departemen Patologi Klinik, FKUI- Background Neonatal sepsis : Early-onset Late-onset Early-onset : mostly premature neonates Within 24 hours 85% 24-48 hours

More information

BACTERIAL INTERVENTIONS TO INCREASE BLOOD SAFETY

BACTERIAL INTERVENTIONS TO INCREASE BLOOD SAFETY BACTERIAL INTERVENTIONS TO INCREASE BLOOD SAFETY Jennifer Allen National Bacteriology Laboratory on behalf of Dr. C P McDonald Head of Bacteriology National Bacteriology Laboratory NHSBT Klebsiella oxytoca

More information

Evaluation of the feasibility of the VACUETTE Urine CCM tube for microbial testing of urine samples

Evaluation of the feasibility of the VACUETTE Urine CCM tube for microbial testing of urine samples Evaluation of the feasibility of the VACUETTE Urine CCM tube for microbial testing of urine samples Background The VACUETTE Urine CCM tube is for the collection, transport and storage of urine samples

More information

1. Which of the following statements concerning Plasmodium vivax is TRUE?

1. Which of the following statements concerning Plasmodium vivax is TRUE? 1 Microm 301 Final Exam 2012 Practice Questions and Key 1. Which of the following statements concerning Plasmodium vivax is TRUE? A. It infects all stages of erythrocytes (immature, mature, and senescent).

More information

MENU PRODUCT MOLECULAR. International Product Listing. Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs

MENU PRODUCT MOLECULAR. International Product Listing. Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs International Product Listing MOLECULAR PRODUCT MENU Simplexa Molecular Kits Integrated Cycler Molecular Reagents and Primer Pairs Products are not intended for donor screening. Simplexa Molecular Kits

More information

Chapter 18. Viral Genetics. AP Biology

Chapter 18. Viral Genetics. AP Biology Chapter 18. Viral Genetics 2003-2004 1 A sense of size Comparing eukaryote bacterium virus 2 What is a virus? Is it alive? DNA or RNA enclosed in a protein coat Viruses are not cells Extremely tiny electron

More information

New Advances in Transfusion EM I LY CO BERLY, M D

New Advances in Transfusion EM I LY CO BERLY, M D New Advances in Transfusion EM I LY CO BERLY, M D TRANSFUSI ON M EDI CI NE FELLO W VANDERBI LT UNI VERSITY Objectives To discuss the terminology, components, transfusion risks, and dosing guidelines for

More information

Page 32 AP Biology: 2013 Exam Review CONCEPT 6 REGULATION

Page 32 AP Biology: 2013 Exam Review CONCEPT 6 REGULATION Page 32 AP Biology: 2013 Exam Review CONCEPT 6 REGULATION 1. Feedback a. Negative feedback mechanisms maintain dynamic homeostasis for a particular condition (variable) by regulating physiological processes,

More information

ICVH 2016 Oral Presentation: 28

ICVH 2016 Oral Presentation: 28 Ledipasvir/Sofosbuvir Is Safe and Effective for the Treatment of Patients with Genotype 1 Chronic HCV Infection in Both HCV Mono- and HIV/HCV Coinfected Patients A Luetkemeyer 1, C Cooper 2, P Kwo 3, K

More information

Probiotics: Their Role in Medicine Today. Objectives. Probiotics: What Are They? 11/3/2017

Probiotics: Their Role in Medicine Today. Objectives. Probiotics: What Are They? 11/3/2017 Probiotics: Their Role in Medicine Today Viki Barr Pharm.D., BCPS AQ ID Assistant Professor, Pharmacy Practice Rosalind Franklin University of Medicine and Science Clinical Pharmacist, Infectious Diseases

More information

Glecaprevir-Pibrentasvir in HCV GT 1 or 4 & Prior DAA Treatment MAGELLAN-1 (Part 2)

Glecaprevir-Pibrentasvir in HCV GT 1 or 4 & Prior DAA Treatment MAGELLAN-1 (Part 2) Phase 3 Treatment-Experienced in HCV GT 1 or 4 & Prior DAA Treatment MAGELLAN-1 (Part 2) in HCV GT 1 or 4 & Prior DAA Treatment MAGELLAN-1 (Part 2): Study Features MAGELLAN-1 (Part 2) Trial Design: Randomized,

More information

ESCMID Online Lecture Library. by author

ESCMID Online Lecture Library. by author Factors influencing the results of metronidazole resistance testing Elisabeth Nagy Institute of Clinical Microbiology, University of Szeged, National Anaerobe Reference Laboratory, Szeged, Hungary Postgraduate

More information

Introducing the World s First Self-Sanitizing UV Germicidal Keyboard and Mouse Solution

Introducing the World s First Self-Sanitizing UV Germicidal Keyboard and Mouse Solution Introducing the World s First Self-Sanitizing UV Germicidal Keyboard and Mouse Solution Vioguard is committed to developing innovative products that help organizations stop the spread of harmful bacteria

More information

REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath)

REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath) REGULATIONS FOR THE POSTGRADUATE DIPLOMA IN MOLECULAR AND DIAGNOSTIC PATHOLOGY (PDipMDPath) (See also General Regulations and Regulations for Taught Postgraduate Curricula) M.129 Admission requirements

More information

ResFinder 4.0: towards in silico antibiograms

ResFinder 4.0: towards in silico antibiograms ResFinder 4.0: towards in silico antibiograms Valeria Bortolaia, DVM, PhD Research group for Genomic Epidemiology National Food Institute Technical University of Denmark The path to WGS-based AMR prediction

More information

Disease causing organisms Resistance Immunity

Disease causing organisms Resistance Immunity Part 1 Disease causing organisms Resistance Immunity Bacteria Most common pathogens Anthrax Cholera Staphylococcus epidermidis bacteria Bacterial diseases Tuberculosis Cholera Bubonic Plague Tetanus Effects

More information

Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics. Deborah Cook

Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics. Deborah Cook Current Concepts in VAP: Stress Ulcer Prophylaxis & Probiotics Deborah Cook Objectives VAP The Old: Gastropulmonary route of infection The New: Microbiome modification Role of acid suppression Influence

More information

Unit 9 New life College faculty: Ramesh Kumar Subject: Life Sciences date: 15jan 2016

Unit 9 New life College faculty: Ramesh Kumar Subject: Life Sciences date: 15jan 2016 Unit 9 New life College faculty: Ramesh Kumar Subject: Life Sciences date: 15jan 2016 History and impact The types and functions of cells in the immune system. How cells communicate and recognize antigen

More information

Healthcare-associated infections acquired in intensive care units

Healthcare-associated infections acquired in intensive care units SURVEILLANCE REPORT Annual Epidemiological Report for 2015 Healthcare-associated infections acquired in intensive care units Key facts In 2015, 11 788 (8.3%) of patients staying in an intensive care unit

More information

Carbapenem-resistant infections on the rise in Europe Presentation by Dr Marc Sprenger, ECDC director, Brussels Press Club, 15 November 2013

Carbapenem-resistant infections on the rise in Europe Presentation by Dr Marc Sprenger, ECDC director, Brussels Press Club, 15 November 2013 ECDC DIRECTOR S PRESENTATION Carbapenem-resistant infections on the rise in Europe Presentation by Dr Marc Sprenger, ECDC director, Brussels Press Club, 15 November 2013 For the launch of the 6th European

More information

EUCAST Frequently Asked Questions. by author. Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator

EUCAST Frequently Asked Questions. by author. Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator EUCAST Frequently Asked Questions Rafael Cantón Hospital Universitario Ramón y Cajal, Madrid, Spain EUCAST Clinical Data Coordinator Erika Matuschek EUCAST Development Laboratory, Växjö Sweden Monday 24

More information

Table of Contents (continued)

Table of Contents (continued) Emerging Molecular and Immunohematology Blood Typing, Grouping And Infectious Disease NAT Screening Assays And Companies Developing New Technologies and Products Table of Contents 1. Blood Typing and Grouping

More information

Viruses. Rotavirus (causes stomach flu) HIV virus

Viruses. Rotavirus (causes stomach flu) HIV virus Viruses Rotavirus (causes stomach flu) HIV virus What is a virus? A virus is a microscopic, infectious agent that may infect any type of living cell. Viruses must infect living cells in order to make more

More information

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers

Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Analysis of Massively Parallel Sequencing Data Application of Illumina Sequencing to the Genetics of Human Cancers Gordon Blackshields Senior Bioinformatician Source BioScience 1 To Cancer Genetics Studies

More information

Communicable diseases. Gastrointestinal track infection. Sarkhell Araz MSc. Public health/epidemiology

Communicable diseases. Gastrointestinal track infection. Sarkhell Araz MSc. Public health/epidemiology Communicable diseases Gastrointestinal track infection Sarkhell Araz MSc. Public health/epidemiology Communicable diseases : Refer to diseases that can be transmitted and make people ill. They are caused

More information

Shaun Yang, PhD, D(ABMM), MLS(ASCP) CM MB CM Assistant Professor of Pathology UNM Health Sciences Center Associate Director of Infectious Disease

Shaun Yang, PhD, D(ABMM), MLS(ASCP) CM MB CM Assistant Professor of Pathology UNM Health Sciences Center Associate Director of Infectious Disease Shaun Yang, PhD, D(ABMM), MLS(ASCP) CM MB CM Assistant Professor of Pathology UNM Health Sciences Center Associate Director of Infectious Disease Director of Molecular Infectious Disease TriCore Reference

More information

Fellow GU Lecture Series, Prostate Cancer. Asit Paul, MD, PhD 02/20/2018

Fellow GU Lecture Series, Prostate Cancer. Asit Paul, MD, PhD 02/20/2018 Fellow GU Lecture Series, 2018 Prostate Cancer Asit Paul, MD, PhD 02/20/2018 Disease Burden Screening Risk assessment Treatment Global Burden of Prostate Cancer Prostate cancer ranked 13 th among cancer

More information

Naturally derived Alcohol free Proven efficiency

Naturally derived Alcohol free Proven efficiency Naturally derived Alcohol free Proven efficiency The issue Indirect transmission commonly occurs by touching the eyes, nose or mouth after contact with surfaces contaminated by the virus. PFP Natural is

More information

Anti-Infective Clinical Trials

Anti-Infective Clinical Trials Anti-Infective Clinical Trials The extensive clinical training and experience of our infectious disease staff places us in a unique position to fully appreciate the requirements of our clients conducting

More information

Most pathogenic Staph cause infection after a breach in the skin. PrepTalk Clicker Questions. First Case - Lulu. Diagnostic information

Most pathogenic Staph cause infection after a breach in the skin. PrepTalk Clicker Questions. First Case - Lulu. Diagnostic information Most pathogenic Staph cause infection after a breach in the skin. PrepTalk Clicker Questions A. True B. False Did you Prep? Which factor is most strongly correlated with the virulence of pathogenic staphylococci?

More information

All POOPed out: fecal microbiota transplant in C. difficile

All POOPed out: fecal microbiota transplant in C. difficile All POOPed out: fecal microbiota transplant in C. difficile SUSAN M. KELLIE, MD, MPH PROFESSOR OF INTERNAL MEDICINE DIVISION OF INFECTIOUS DISEASES UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE HOSPITAL

More information

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University

Medical Virology Immunology. Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Medical Virology Immunology Dr. Sameer Naji, MB, BCh, PhD (UK) Head of Basic Medical Sciences Dept. Faculty of Medicine The Hashemite University Human blood cells Phases of immune responses Microbe Naïve

More information

I. Bacteria II. Viruses including HIV. Domain Bacteria Characteristics. 5. Cell wall present in many species. 6. Reproduction by binary fission

I. Bacteria II. Viruses including HIV. Domain Bacteria Characteristics. 5. Cell wall present in many species. 6. Reproduction by binary fission Disease Diseases I. Bacteria II. Viruses including are disease-causing organisms Biol 105 Lecture 17 Chapter 13a Domain Bacteria Characteristics 1. Domain Bacteria are prokaryotic 2. Lack a membrane-bound

More information

The Bacteriology of Bronchiectasis in Australian Indigenous children

The Bacteriology of Bronchiectasis in Australian Indigenous children The Bacteriology of Bronchiectasis in Australian Indigenous children Kim Hare, Amanda Leach, Peter Morris, Heidi Smith-Vaughan, Anne Chang Presentation outline What is bronchiectasis? Our research at Menzies

More information

Influence of Different Prebiotics and Probiotics on Selective Intestinal Pathogens

Influence of Different Prebiotics and Probiotics on Selective Intestinal Pathogens ISSN: 2319-7706 Volume 3 Number 10 (2014) pp. 657-663 http://www.ijcmas.com Original Research Article Influence of Different Prebiotics and Probiotics on Selective Intestinal Pathogens Anayata Sharma 1*

More information

ONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing

ONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing SUMMARY OF ANTIMICROBIAL ACTIVITY ONE STEP (Lemon, Mint, Pine) Detergent for Cleaning, Disinfecting and Deodorizing Description One Step is an effective economical 4 ounce per gallon disinfectant, specifically

More information

Enhanced EARS-Net Surveillance REPORT FOR 2012 DATA

Enhanced EARS-Net Surveillance REPORT FOR 2012 DATA Enhanced EARS-Net Surveillance REPORT FOR DATA 1 In this report Main results for Proposed changes to the enhanced programme Abbreviations Used Here BSI Bloodstream Infections CVC Central Venous Catheter

More information

Normal Flora PROF. HANAN HABIB DEPARTMENT OF PATHOLOGY COLLEGE OF MEDICINE, KSU

Normal Flora PROF. HANAN HABIB DEPARTMENT OF PATHOLOGY COLLEGE OF MEDICINE, KSU Normal Flora PROF. HANAN HABIB DEPARTMENT OF PATHOLOGY COLLEGE OF MEDICINE, KSU Objectives 1. Define the terms: Normal Flora, Resident flora, Transient flora and carrier state 2. Know the origin of normal

More information